arXiv.itsnick.co

an independent field guide to 23 million papers from arXiv & OpenAlex — not affiliated with arXiv.org

Author

Neal Jeffries

6 papers · 2003–2024

2003: 12004: 02005: 02006: 02007: 02008: 02009: 02010: 02011: 02012: 02013: 02014: 02015: 12016: 02017: 12018: 02019: 12020: 02021: 02022: 12023: 02024: 1
2003peak 1 in 20032024

Frequent co-authors

Papers

showing 1–6 of 6 RSS

Methodological Approaches to Understanding Causes of Health Disparities

Neal Jeffries, Alan M. Zaslavsky, Ana V. Diez Roux +9 more

Health · American Journal of Public Health · · cited 100× · DOI ↗ · more like this ·

Understanding health disparity causes is an important first step toward developing policies or interventions to eliminate disparities, but their nature makes identifying and addressing their causes challenging. Potential causal factors are often correlated, making it difficult to distinguish their effects. These factors may exist at different organizational levels (e.g., individual, family, neighborhood), each of which needs to be appropriately conceptualized and measured. The processes that generate health disparities may include complex relationships with feedback loops and dynamic properties that traditional statistical models represent poorly. Because of this complexity, identifying disparities' causes and remedies requires integrating findings from multiple methodologies. We highlight analytic methods and designs, multilevel approaches, complex systems modeling techniques, and…

A note on 'Testing the number of components in a normal mixture'

Neal Jeffries

Artificial Intelligence · Biometrika · · cited 75× · DOI ↗ · more like this ·

In a recent paper, Lo et al. (2001) propose a test for the likelihood ratio statistic based on the Kullback--Leibler information criterion when testing the null hypothesis that a random sample is drawn from a mixture of k-sub-0 normal components against the alternative hypothesis of a mixture with k-sub-1 normal components with k-sub-0 less than k-sub-1. However, this result requires conditions that are generally not met when the null hypothesis holds. Consequently, the result is not proven and simulations suggest that it may not be correct. Copyright Biometrika Trust 2003, Oxford University Press.

Use of win time for ordered composite endpoints in clinical trials

James Troendle, Eric Leifer, Song Yang +4 more

Statistics and Probability · Statistics in Medicine · · cited 6× · DOI ↗ · more like this ·

Consider the choice of outcome for overall treatment benefit in a clinical trial which measures the first time to each of several clinical events. We describe several new variants of the win ratio that incorporate the time spent in each clinical state over the common follow-up, where clinical state means the worst clinical event that has occurred by that time. One version allows restriction so that death during follow-up is most important, while time spent in other clinical states is still accounted for. Three other variants are described; one is based on the average pairwise win time, one creates a continuous outcome for each participant based on expected win times against a reference distribution and another that uses the estimated distributions of clinical state to compare the treatment arms. Finally, a combination testing approach is described to give robust power for detecting…

Detecting Treatment Differences in Group Sequential Longitudinal Studies with Covariate Adjustment

Neal Jeffries, James Troendle, Nancy L. Geller

Statistics and Probability · Biometrics · · cited 5× · DOI ↗ · more like this ·

In longitudinal studies comparing two treatments over a series of common follow-up measurements, there may be interest in determining if there is a treatment difference at any follow-up period when there may be a non-monotone treatment effect over time. To evaluate this question, Jeffries and Geller (2015) examined a number of clinical trial designs that allowed adaptive choice of the follow-up time exhibiting the greatest evidence of treatment difference in a group sequential testing setting with Gaussian data. The methods are applicable when a few measurements were taken at prespecified follow-up periods. Here, we test the intersection null hypothesis of no difference at any follow-up time versus the alternative that there is a difference for at least one follow-up time. Results of Jeffries and Geller (2015) are extended by considering a broader range of modeled data and the inclusion…

Longitudinal Clinical Trials with Adaptive Choice of Follow-Up Time

Neal Jeffries, Nancy L. Geller

Statistics and Probability · Biometrics · · cited 5× · DOI ↗ · more like this ·

In longitudinal studies comparing two treatments with a maximum follow-up time there may be interest in examining treatment effects for intermediate follow-up times. One motivation may be to identify the time period with greatest treatment difference when there is a non-monotone treatment effect over time; another motivation may be to make the trial more efficient in terms of time to reach a decision on whether a new treatment is efficacious or not. Here, we test the composite null hypothesis of no difference at any follow-up time versus the alternative that there is a difference at at least one follow-up time. The methods are applicable when a few measurements are taken over time, such as in early longitudinal trials or in ancillary studies. Suppose the test statistic Z(t(k)) will be used to test the hypothesis of no treatment effect at a fixed follow-up time t(k). In this context a…

Evaluating Treatment Effects in Group Sequential Multivariate Longitudinal Studies with Covariate Adjustment

Neal Jeffries, James Troendle, Nancy L. Geller

Statistics and Probability · Biometrics · · cited 2× · DOI ↗ · more like this ·

Jeffries et al. (2018) investigated testing for a treatment difference in the setting of a randomized clinical trial with a single outcome measured longitudinally over a series of common follow-up times while adjusting for covariates. That paper examined the null hypothesis of no difference at any follow-up time versus the alternative of a difference for at least one follow-up time. We extend those results here by considering multivariate outcome measurements, where each individual outcome is examined at common follow-up times. We consider the case where there is interest in first testing for a treatment difference in a global function of the outcomes (e.g., weighted average or sum) with subsequent interest in examining the individual outcomes, should the global function show a treatment difference. Testing is conducted for each follow-up time and may be performed in the setting of a…